Advanced search
Publication Cover
Leukemia & Lymphoma Volume 57, 2016 - Issue 6
Submit an article Journal homepage
422
Views
32
CrossRef citations to date
0
Altmetric
Original Articles: Clinical

Hepatitis B virus reactivation after withdrawal of prophylactic antiviral therapy in patients with diffuse large B cell lymphoma

Wei Ping LiuKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Lymphoma, Peking University Cancer Hospital & Institute, Beijing, China;
,
Xiao Pei WangKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Lymphoma, Peking University Cancer Hospital & Institute, Beijing, China;
,
Wen ZhengKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Lymphoma, Peking University Cancer Hospital & Institute, Beijing, China;
,
Ling Yan PingKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Lymphoma, Peking University Cancer Hospital & Institute, Beijing, China;
,
Chen ZhangKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Lymphoma, Peking University Cancer Hospital & Institute, Beijing, China;
,
Gui Qiang WangDepartment of Infectious Diseases, Center for Liver Diseases, Peking University First Hospital, Beijing, China
,
Yu Qin SongKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Lymphoma, Peking University Cancer Hospital & Institute, Beijing, China;
&
Jun ZhuKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Lymphoma, Peking University Cancer Hospital & Institute, Beijing, China; Correspondence[email protected]
 show all
Pages 1355-1362 | Received 31 Jul 2015, Accepted 31 Oct 2015, Published online: 04 Jan 2016

Citations (32)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (6)

Maria Gabriela Fernandes Dezan, Lourianne Nascimento Cavalcante, Helma Pinchemel Cotrim & Andre Castro Lyra. (2023) Hepatobiliary disease after bone marrow transplant. Expert Review of Gastroenterology & Hepatology 17:2, pages 129-143.
Read now
Min-Yue Zhang, Fei Gao, Yan-Wei Zhao, Bei-Wen Ni, Hong-Hui Huang & Jian Hou. (2022) Inferior survival and frequent hepatic dysfunction in non-Hodgkin’s lymphoma patients with HBV infection: a systematic review and meta-analysis. Hematology 27:1, pages 70-79.
Read now
Edward R. Scheffer Cliff, Joe Sasadeusz, Kumar Visvanathan & Andrew Grigg. (2022) Very late-onset hepatitis B reactivation following chemoimmunotherapy. Leukemia & Lymphoma 63:4, pages 991-995.
Read now
Shunfeng Hu, Na Chen, Kang Lu, Changqing Zhen, Xiaohui Sui, Xiaosheng Fang, Ying Li, Yingshu Luo, Xiangxiang Zhou & Xin Wang. (2021) The prognostic roles of hepatitis B virus antibody in diffuse large B-cell lymphoma patients. Leukemia & Lymphoma 62:6, pages 1335-1343.
Read now
Shang-Chin Huang, Hung-Chih Yang & Jia-Horng Kao. (2020) Hepatitis B reactivation: diagnosis and management. Expert Review of Gastroenterology & Hepatology 14:7, pages 565-578.
Read now
Deborah Rund. (2016) Prophylaxis for hepatitis B reactivation during and after chemotherapy: many questions, some answers. Leukemia & Lymphoma 57:6, pages 1249-1250.
Read now

Articles from other publishers (26)

Zhu Jiayu & Qingyuan Zhang. (2023) Hepatitis B virus–associated diffuse large B cell lymphoma: epidemiology, biology, clinical features and HBV reactivation. Holistic Integrative Oncology 2:1.
Crossref
Reyizha Nuersulitan, Miaomiao Li, Lan Mi, Meng Wu, Xinqiang Ji, Yiqi Liu, Hong Zhao, Guiqiang Wang, Yuqin Song, Jun Zhu & Weiping Liu. (2022) Effect of infection with hepatitis B virus on the survival outcome of diffuse large B-cell lymphoma in the prophylactic antiviral era. Frontiers in Oncology 12.
Crossref
. (2022) KASL clinical practice guidelines for management of chronic hepatitis B. Clinical and Molecular Hepatology 28:2, pages 276-331.
Crossref
Nathália Alves Araujo de Almeida & Vanessa Salete de Paula. (2022) Occult Hepatitis B virus (HBV) infection and challenges for hepatitis elimination: A literature review. Journal of Applied Microbiology 132:3, pages 1616-1635.
Crossref
Ilkay Bozkurt, Hatun Ozturk Cerik, Seher Kir, Muge Ustaoglu, Mehmet Turgut & Saban Esen. (2021) Evaluation of Hepatitis B screening and reactivation in patients receiving rituximab containing chemotherapy: A single‐centre study. International Journal of Clinical Practice 75:10.
Crossref
Guiqiang Wang & Zhongping Duan. (2021) Guidelines for Prevention and Treatment of Chronic Hepatitis B. Journal of Clinical and Translational Hepatology 000:000, pages 000-000.
Crossref
Xing Cao, Yafei Wang, Panyun Li, Wei Huang, Xiaojuan Lu & Hongda Lu. (2021) HBV Reactivation During the Treatment of Non-Hodgkin Lymphoma and Management Strategies. Frontiers in Oncology 11.
Crossref
Branko Borojevic, Ayushi Chauhan & Scott Patterson. (2021) Liver failure from delayed hepatitis B reactivation in anti-HBc-positive patient following rituximab for B-cell lymphoma. BMJ Case Reports 14:7, pages e243526.
Crossref
Hyung Joon Yim, Ji Hoon Kim, Jun Yong Park, Eileen L. Yoon, Hana Park, Jung Hyun Kwon, Dong Hyun Sinn, Sae Hwan Lee, Jeong-Hoon Lee & Hyun Woong Lee. (2020) Comparison of clinical practice guidelines for the management of chronic hepatitis B: When to start, when to change, and when to stop. Clinical and Molecular Hepatology 26:4, pages 411-429.
Crossref
Dimitrios C Ziogas, Frosso Kostantinou, Evangelos Cholongitas, Amalia Anastasopoulou, Panagiotis Diamantopoulos, John Haanen & Helen Gogas. (2020) Reconsidering the management of patients with cancer with viral hepatitis in the era of immunotherapy. Journal for ImmunoTherapy of Cancer 8:2, pages e000943.
Crossref
Soo-Kyung Park, Chang Hwan Choi, Jaeyoung Chun, Heeyoung Lee, Eun Sun Kim, Jae Jun Park, Chan Hyuk Park, Bo-In Lee, Yunho Jung, Dong-Il Park, Do Young Kim, Hana Park & Yoon Tae Jeen. (2020) Prevention and management of viral hepatitis in inflammatory bowel disease: a clinical practice guideline by the Korean Association for the Study of Intestinal Diseases. Intestinal Research 18:1, pages 18-33.
Crossref
Yu-Fen Tsai, Ching-I Yang, Jeng-Shiun Du, Ming-Hui Lin, Shih-Hao Tang, Hui-Ching Wang, Shih-Feng Cho, Yi-Chang Liu, Yu-Chieh Su, Chia-Yen Dai & Hui-Hua Hsiao. (2019) Rituximab increases the risk of hepatitis B virus reactivation in non-Hodgkin lymphoma patients who are hepatitis B surface antigen-positive or have resolved hepatitis B virus infection in a real-world setting: a retrospective study. PeerJ 7, pages e7481.
Crossref
Tsutomu Nishida, Tokuhiro Matsubara, Takayuki Yakushijin & Masami Inada. (2019) Prediction and clinical implications of HBV reactivation in lymphoma patients with resolved HBV infection: focus on anti-HBs and anti-HBc antibody titers. Hepatology International 13:4, pages 407-415.
Crossref
. (2019) KASL clinical practice guidelines for management of chronic hepatitis B. Clinical and Molecular Hepatology 25:2, pages 93-159.
Crossref
Eileen L. Yoon & Hyung Joon Yim. (2019) Updated Treatment of Chronic Hepatitis B. The Korean Journal of Medicine 94:3, pages 252-262.
Crossref
Hannah M. Lee & Bubu A. Banini. (2019) Updates on Chronic HBV: Current Challenges and Future Goals. Current Treatment Options in Gastroenterology 17:2, pages 271-291.
Crossref
Rhiannon M. Bath, Brandelyn E. Doering, Michael D. Nailor & Kellie J. Goodlet. (2018) Pharmacotherapy-Induced Hepatitis B Reactivation Among Patients With Prior Functional Cure: A Systematic Review. Annals of Pharmacotherapy 53:3, pages 294-310.
Crossref
Wei Ping Liu, Xiu Bin Xiao, Mei Xue, Gui Qiang Wang, Xiao Pei Wang, Yu Qin Song & Jun Zhu. (2019) Prophylactic Use of Entecavir for Lymphoma Patients With Past Hepatitis B Virus Infection: A Randomized Controlled Trial. Clinical Lymphoma Myeloma and Leukemia 19:2, pages 103-108.
Crossref
Eileen L. Yoon. (2019) Prophylactic Antiviral Treatment in Immunosuppressed Chronic Hepatitis B Patients. The Korean Journal of Gastroenterology 74:5, pages 258.
Crossref
Ji Hoon Kim. (2019) 2018 Korean Association for the Study of the Liver (KASL) Clinical Practice Guidelines of Chronic Hepatitis B: What's Different?. The Korean Journal of Gastroenterology 73:3, pages 132.
Crossref
M. Fujita, M. Sugiyama, Y. Sato, K. Nagashima, S. Takahashi, M. Mizokami & A. Hata. (2018) Hepatitis B virus reactivation in patients with rheumatoid arthritis: Analysis of the National Database of Japan. Journal of Viral Hepatitis 25:11, pages 1312-1320.
Crossref
Norah A. Terrault, Anna S.F. Lok, Brian J. McMahon, Kyong‐Mi Chang, Jessica P. Hwang, Maureen M. Jonas, Robert S. Brown, Natalie H. Bzowej & John B. Wong. (2018) Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology 67:4, pages 1560-1599.
Crossref
Matthew Kelling, Lubomir Sokol & Samir Dalia. (2018) Hepatitis B Reactivation in the Treatment of Non-Hodgkin Lymphoma. Cancer Control 25:1, pages 107327481876787.
Crossref
Zhefeng Sui, Ying Shi, Zhiling Gao, Deguang Yang & Zhihao Wang. (2017) Expression of programmed cell death1 in T follicular helper cells is regulated by prostaglandin E2 secreted by HBV-infected HepG2.2.1.5 cells. Molecular Medicine Reports.
Crossref
Venessa Pattullo. (2016) Prevention of Hepatitis B reactivation in the setting of immunosuppression. Clinical and Molecular Hepatology 22:2, pages 219-237.
Crossref
Man Fai Law, Rita Ho, Carmen K M Cheung, Lydia H P Tam, Karen Ma, Kent C Y So, Bonaventure Ip, Jacqueline So, Jennifer Lai, Joyce Ng & Tommy H C Tam. (2016) Prevention and management of hepatitis B virus reactivation in patients with hematological malignancies treated with anticancer therapy. World Journal of Gastroenterology 22:28, pages 6484.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.